Medical Disclaimer
The information on this page is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.
Always seek the advice of your doctor or other qualified health professional with any questions you may have regarding a medical condition.
π¨Emergency? If you have severe symptoms, difficulty breathing, or think it's an emergency, call 000 immediately.
Mucopolysaccharidoses (MPS) in Children
Mucopolysaccharidoses (MPS) are rare inherited disorders that affect bones, joints, and other organs. Learn about the different types (Hurler, Hunter, Morquio syndromes), skeletal complications, enzyme replacement therapy, and orthopaedic management.
πWhat is Mucopolysaccharidoses (MPS) in Children?
Mucopolysaccharidoses (MPS) are rare inherited disorders that affect bones, joints, and other organs. Learn about the different types (Hurler, Hunter, Morquio syndromes), skeletal complications, enzyme replacement therapy, and orthopaedic management.
π¬What Causes It?
- MPS disorders are caused by genetic mutations affecting enzymes that break down glycosaminoglycans (GAGs, previously called mucopolysaccharides)
- Without these enzymes, GAGs accumulate in cells throughout the body - bones, cartilage, heart valves, brain, causing progressive damage
- Inherited in autosomal recessive pattern (both parents are carriers) or X-linked recessive (Hunter syndrome)
- Not caused by anything parents did during pregnancy - it's genetic
β οΈRisk Factors
You may be at higher risk if:
- Family history of MPS (both parents must be carriers for most types)
- Consanguinity (parents are blood relatives - increases carrier pairing risk)
- Certain ethnic backgrounds (some MPS types more common in specific populations)
- Overall very rare: 1 in 25,000 to 1 in 100,000 births depending on type
- Hunter syndrome (MPS II) only affects boys (X-linked)
π‘οΈPrevention
- βMPS cannot be prevented - it's genetic
- βGenetic counseling recommended for families with MPS child planning more children (25% recurrence risk for autosomal recessive types)
- βPrenatal testing available (amniocentesis, CVS) if parents are known carriers
- βPreimplantation genetic diagnosis (PGD) with IVF can select unaffected embryos
- βPopulation carrier screening not currently done (conditions too rare)
- βEarly diagnosis through newborn screening being introduced in some countries (allows earlier treatment)